Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PhRMA policy VP

Executive Summary

Wendy Krasner named Pharmaceutical Research & Manufacturers of America's deputy VP-policy, where she will head new public programs unit of the association's Policy & Research Division. Krasner joins from the D.C. law firm McDermott, Will & Emery, where she was a partner and co-chaired the managed care practice; before that she was an HHS attorney. She will report to Senior VP Rick Smith, who recently gained responsibility for strategic communications in addition to his previous role as policy head (1"The Pink Sheet" April 14, p. 21)...

You may also be interested in...



PhRMA Reorganizes PR; Policy VP Smith Will Also Head Communications

PhRMA is combining its policy and communications efforts under Senior VP Richard Smith

Woodcock Faces Maze Of Rules To Become Commissioner Nominee

Vacancies Reform Act requires individual in an acting position to step down in order to be nominated to the permanent post but there are exceptions. Andrew von Eschenbach retained acting title during his nomination in 2006.

Even As Acting US FDA Commissioner, Woodcock Still Holds Multiple Positions

To help with the transition to Biden’s COVID-19 response, Woodcock will retain some therapeutic development duties in the program the Trump administration had called Operation Warp Speed.

UsernamePublicRestriction

Register

OM011381

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel